Market Overview

Morning Market Movers

Related CYTR
Tuesday's Morning Movers: FXCM Takes Another Big Drop
Aegis Capital Reiterates Buy On CytRx As Stock Soars 17%
CytRx Candidate Encourages in Soft Tissue Sarcoma Study - Analyst Blog (Zacks)
Related BGMD
Earnings Scheduled For August 14, 2014
Healthways, Genesis Physicians Group Unite to Enhance Healthcare - Analyst Blog
PAREXEL International Q2 Earnings, Revenues Top Estimates - Analyst Blog (Zacks)

CytRx (NASDAQ: CYTR) rose 68.20% to $4.02 on positive Phase 2B data.

BG Medicine (NASDAQ: BGMD) moved up 41.67% to $1.53 after the company confirmed final determination by CMS of 2014 reimbursement for BGM galectin-3 test.

LiveDeal (NASDAQ: LIVE) shares jumped 21.34% to $3.98 after the company announced the launch of in Los Angeles.

NanoString Technologies (NASDAQ: NSTG) jumped 17.30% to $16.48 as the company announced adoption of the Prosigna Breast Cancer Assay by leading US clinical laboratories and cancer centers.

Posted-In: market moversNews Intraday Update Markets Movers


Related Articles (CYTR + BGMD)

Around the Web, We're Loving...

Get Benzinga's Newsletters